
Paleno 75mg Capsule
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Palbociclib (75mg)
Overview Paleno 75mg Capsule
Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with 75mg Paleno capsules, administered alongside hormonal cancer therapies. For optimal absorption, ingest this medication with food at the same time daily, as prescribed by your physician. Dosage and frequency are individualized and subject to change based on your treatment response. Strict adherence to your doctor's instructions is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, potentially taking weeks or months. Discontinue use only under your doctor's guidance. Common side effects include tiredness, alopecia, skin rashes, nausea, and diarrhea. Paleno can reduce blood cell counts, increasing infection risk. Report any signs of infection (fever, chills, weakness), bleeding/bruising, or nosebleeds to your doctor. Dizziness may occur; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, as well as all current medications, including antibiotics, to your doctor. Potential drug interactions exist; ensure your healthcare provider is aware of all your medications. Paleno is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Paleno 75mg Capsule
No text provided. Please provide the text you want me to rephrase.
Uses of Paleno 75mg Capsule
Malignant breast tumor
Major Benefits of Paleno 75mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Paleno 75mg Capsules. Administer this medication with food.
Common Side effects of Paleno 75mg Capsule:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Paleno 75mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Paleno 75mg Capsules with food.
How Paleno 75mg Capsule works:
Paleno 75mg capsules are an anticancer drug that targets the cell cycle. It functions by blocking cyclin-dependent kinases 4 and 6, key proteins driving cellular growth and division. By inhibiting these signaling molecules, Paleno arrests the progression of the cancer cell cycle. This mechanism is particularly effective against estrogen receptor-positive breast cancers, where it disrupts the cellular processes fueling tumor development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Paleno 75mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Paleno 75mg Capsules during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and Paleno 75mg capsules are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Paleno 75mg Capsules, as they can induce tiredness in certain individuals. Therefore, operating vehicles or machinery requires extra care if fatigue occurs.
KidneySAFE IF PRESCRIBED
Paleno 75mg capsules pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Paleno 75mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Paleno 75mg Capsule :
NA
Facts to Know About Paleno 75mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavioral Class | CDK Inhibitor |
